لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Jochems A; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Schouwenburg MG; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Leeneman B; Institute for Medical Technology Assessment, Erasmus University, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., Franken MG; Institute for Medical Technology Assessment, Erasmus University, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., van den Eertwegh AJ; Department of Medical Oncology, VU University Medical Centre, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands., Haanen JB; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Uyl-de Groot CA; Institute for Medical Technology Assessment, Erasmus University, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., Aarts MJ; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands., van den Berkmortel FW; Department of Internal Medicine, Zuyderland Medical Centre Heerlen-Sittard, Henri Dunantstraat 5, 6419 PC, Heerlen, The Netherlands., Blokx WA; Department of Pathology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Cardous-Ubbink MC; Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands., Groenewegen G; Department of Medical Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3582, CX, Utrecht, The Netherlands., de Groot JW; Department of Medical Oncology, Isala, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands., Hospers GA; Department of Medical Oncology, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Koornstra RH; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Kruit WH; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands., Louwman MW; Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Henri Dunantweg 2, 8934 AD, Leeuwarden, The Netherlands., Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Molengracht 21, 4818 CK, Breda, The Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, 5504 DB, Eindhoven, The Netherlands., Wouters MW; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van der Hoeven JJ; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. Electronic address: J.J.M.van_der_Hoeven@lumc.nl.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Feb; Vol. 72, pp. 156-165. Date of Electronic Publication: 2016 Dec 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Registries*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Melanoma/*drug therapy , Protein Kinase Inhibitors/*therapeutic use , Quality Assurance, Health Care/*methods , Skin Neoplasms/*drug therapy, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cancer Care Facilities/standards ; Clinical Audit/methods ; Cost-Benefit Analysis ; Female ; Humans ; Male ; Melanoma/secondary ; Middle Aged ; Netherlands ; Protein Kinase Inhibitors/adverse effects ; Quality of Health Care ; Quality of Life ; Survival Analysis

المؤلفون: Driessen EJ; Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands. Electronic address: research@viecuri.nl., Bootsma GP; Department of Pulmonology, Zuyderland Medical Centre, Heerlen, The Netherlands., Hendriks LE; Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, The Netherlands., van den Berkmortel FW; Department of Medical Oncology, Zuyderland Medical Centre, Heerlen, The Netherlands., Bogaarts BA; Department of Pulmonology, VieCuri Medical Centre, Venlo, The Netherlands., van Loon JG; MAASTRO Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands., Dingemans AC; Department of Pulmonary Diseases, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, The Netherlands., Janssen-Heijnen ML; Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands; Department of Epidemiology, Maastricht University Medical Centre, GROW School for Oncology and Developmental Biology, The Netherlands.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2016 Oct; Vol. 121 (1), pp. 26-31. Date of Electronic Publication: 2016 Aug 10.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Chemoradiotherapy*, Carcinoma, Non-Small-Cell Lung/*therapy , Lung Neoplasms/*therapy, Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/pathology ; Male ; Neoplasm Staging ; Netherlands ; Registries ; Retrospective Studies ; Survival Analysis

المؤلفون: Vriens BE; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., de Vries B; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands., Lobbes MB; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands., van Gastel SM; Comprehensive Cancer Center the Netherlands, Nijmegen, The Netherlands., van den Berkmortel FW; Department of Internal Medicine, Atrium Medical Center, Heerlen, The Netherlands., Smilde TJ; Department of Internal Medicine, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands., van Warmerdam LJ; Department of Internal Medicine, Catharina-Hospital, Eindhoven, The Netherlands., de Boer M; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., van Spronsen DJ; Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., Smidt ML; Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands., Peer PG; Biostatistics, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Aarts MJ; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Tjan-Heijnen VC; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address: vcg.tjan.heijnen@mumc.nl.

مؤلفون مشاركون: INTENS Study Group

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2016 Jan; Vol. 52, pp. 67-76. Date of Electronic Publication: 2015 Nov 30.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Magnetic Resonance Imaging* , Neoadjuvant Therapy* , Ultrasonography, Mammary*, Breast Neoplasms/*diagnosis , Breast Neoplasms/*drug therapy , Tumor Burden/*drug effects, Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/pathology ; Chemotherapy, Adjuvant ; Female ; Humans ; Netherlands ; Predictive Value of Tests ; Prospective Studies ; Reproducibility of Results ; Treatment Outcome

المؤلفون: Taal W; Department of Neuro-oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Oosterkamp HM; Department of Medical Oncology, Medical Center Haaglanden, The Hague, Netherlands., Walenkamp AM; Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Beerepoot LV; Department of Oncology, St Elisabeth Ziekenhuis, Tilburg, Netherlands., Hanse MC; Department of Neurology, Catharina Hospital Eindhoven, Netherlands., Buter J; Department of Oncology, VU University Medical Center, Amsterdam, Netherlands., Honkoop AH; Department of Internal Medicine, Isala Kliniek, Zwolle, Netherlands., Boerman D; Department of Neurology, Rijnstate, Arnhem, Netherlands., de Vos FY; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, Netherlands., Dinjens WN; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Enting RH; Department of Neurology, University Medical Center Groningen, Groningen, Netherlands., Taphoorn MJ; Department of Neurology, Medical Center Haaglanden, The Hague, Netherlands., van den Berkmortel FW; Department of Oncology, Atrium MC Parkstad, Heerlen, Netherlands., Jansen RL; Department of Oncology, Maastricht Universitair Medisch Centrum, Netherlands., Brandsma D; Department of Neuro-oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Bromberg JE; Department of Neuro-oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., van Heuvel I; Department of Neuro-oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Vernhout RM; Clinical Trial Centre, Erasmus MC Cancer Institute, Rotterdam, Netherlands., van der Holt B; Clinical Trial Centre, Erasmus MC Cancer Institute, Rotterdam, Netherlands., van den Bent MJ; Department of Neuro-oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. Electronic address: m.vandenbent@erasmusmc.nl.

المصدر: The Lancet. Oncology [Lancet Oncol] 2014 Aug; Vol. 15 (9), pp. 943-53. Date of Electronic Publication: 2014 Jul 15.

نوع المنشور: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Brain Neoplasms/*therapy , Glioblastoma/*therapy , Lomustine/*administration & dosage , Neoplasm Recurrence, Local/*drug therapy , Neoplasm Recurrence, Local/*mortality, Administration, Oral ; Adolescent ; Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; Bevacizumab ; Brain Neoplasms/mortality ; Brain Neoplasms/pathology ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Drug Combinations ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Glioblastoma/mortality ; Glioblastoma/pathology ; Humans ; Infusions, Intravenous ; Lomustine/adverse effects ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Survival Analysis ; Young Adult

عنوان ترانسليتريتد: Een genetische kinderziekte met gevolgen op de volwassen leeftijd: Denys-Drash-syndroom.

المؤلفون: Löwik MM; Laboratorium Kindergeneeskunde, Universitair Medisch Centrum St Radboud, Postbus 9101, 6500 HB Nijmegen., van den Berkmortel FW, Noordam C, van Hamersvelt HW, van den Heuvel LP, Levtchenko EN

المصدر: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2005 Jul 30; Vol. 149 (31), pp. 1751-5.

نوع المنشور: Case Reports; English Abstract; Journal Article

بيانات الدورية: Publisher: Vereniging NTvG Country of Publication: Netherlands NLM ID: 0400770 Publication Model: Print Cited Medium: Print ISSN: 0028-2162 (Print) Linking ISSN: 00282162 NLM ISO Abbreviation: Ned Tijdschr Geneeskd Subsets: MEDLINE

مواضيع طبية MeSH: Genes, Wilms Tumor*, Denys-Drash Syndrome/*genetics , Disorders of Sex Development/*genetics , Ovarian Neoplasms/*genetics , Urogenital Abnormalities/*genetics, Adolescent ; Denys-Drash Syndrome/psychology ; Female ; Gonadal Dysgenesis/genetics ; Humans ; Mutation ; Quality of Life

عنوان ترانسليتريتد: Een jonge man met snel progressieve dyspnoe en een mediastinale massa.

المؤلفون: van Spronsen DJ; Afd. Medische Oncologie, Universitair Medisch Centrum St Radboud, Postbus 9101, 6500 HB Nijmegen. d.vanspronsen@onco.umcn.nl, van den Berkmortel FW, Bootsma GP, de Mulder PH

المصدر: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2004 Nov 13; Vol. 148 (46), pp. 2286-9.

نوع المنشور: Case Reports; English Abstract; Journal Article

بيانات الدورية: Publisher: Vereniging NTvG Country of Publication: Netherlands NLM ID: 0400770 Publication Model: Print Cited Medium: Print ISSN: 0028-2162 (Print) Linking ISSN: 00282162 NLM ISO Abbreviation: Ned Tijdschr Geneeskd Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Germinoma/*diagnosis , Mediastinal Neoplasms/*diagnosis, Adolescent ; Bleomycin/administration & dosage ; Chorionic Gonadotropin/blood ; Cisplatin/administration & dosage ; Dyspnea/etiology ; Etoposide/administration & dosage ; Germinoma/drug therapy ; Germinoma/pathology ; Humans ; Male ; Mediastinal Neoplasms/drug therapy ; Mediastinal Neoplasms/pathology ; Remission Induction ; Treatment Outcome ; alpha-Fetoproteins/analysis

المؤلفون: van den Berkmortel FW; Department of Medicine, Division of General Internal Medicine, University Medical Centre, St Radboud, PO Box 9101, 6500 HB Nijmegen, the Netherlands. f.vandenberkmortel@onco.umcn.nl, Wollersheim H, van Langen H, Smilde TJ, den Arend J, Thien T

المصدر: The Netherlands journal of medicine [Neth J Med] 2004 Jul-Aug; Vol. 62 (7), pp. 235-41.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Van Zuiden Communications Country of Publication: Netherlands NLM ID: 0356133 Publication Model: Print Cited Medium: Print ISSN: 0300-2977 (Print) Linking ISSN: 03002977 NLM ISO Abbreviation: Neth J Med Subsets: MEDLINE

مواضيع طبية MeSH: Smoking Cessation*, Carotid Arteries/*pathology , Femoral Artery/*pathology , Smoking/*physiopathology , Tunica Intima/*pathology , Tunica Media/*pathology, Adult ; Carotid Arteries/diagnostic imaging ; Cross-Sectional Studies ; Disease Progression ; Female ; Femoral Artery/diagnostic imaging ; Humans ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Risk Reduction Behavior ; Smoking/adverse effects ; Smoking Prevention ; Surveys and Questionnaires ; Tunica Intima/diagnostic imaging ; Tunica Media/diagnostic imaging ; Ultrasonography

المؤلفون: Peeters AC; University Medical Centre St Radboud, Nijmegen, The Netherlands., Kucharekova M, Timmermans J, van den Berkmortel FW, Boers GH, Nováková IR, Egging D, den Heijer M, Schalkwijk J

المصدر: The Netherlands journal of medicine [Neth J Med] 2004 May; Vol. 62 (5), pp. 160-2.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Van Zuiden Communications Country of Publication: Netherlands NLM ID: 0356133 Publication Model: Print Cited Medium: Print ISSN: 0300-2977 (Print) Linking ISSN: 03002977 NLM ISO Abbreviation: Neth J Med Subsets: MEDLINE

مواضيع طبية MeSH: Ehlers-Danlos Syndrome/*diagnosis , Tenascin/*deficiency, Echocardiography ; Ehlers-Danlos Syndrome/complications ; Ehlers-Danlos Syndrome/genetics ; Ehlers-Danlos Syndrome/metabolism ; Humans ; Mitral Valve Prolapse/complications ; Mitral Valve Prolapse/diagnostic imaging

عنوان ترانسليتريتد: Chirurgische behandeling van tumormetastasen in longen, hersenen of lever.

المؤلفون: van den Berkmortel FW; Afd. Medische Oncologie, Universitair Medisch Centrum St Radboud, Postbus 9101, 6500 HB Nijmegen. f.vandenberkmortel@onco.umcn.nl, Ruers TJ, Bootsma GP, Verhagen AF, de Mulder PH

المصدر: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2003 May 10; Vol. 147 (19), pp. 904-8.

نوع المنشور: English Abstract; Journal Article; Review

بيانات الدورية: Publisher: Vereniging NTvG Country of Publication: Netherlands NLM ID: 0400770 Publication Model: Print Cited Medium: Print ISSN: 0028-2162 (Print) Linking ISSN: 00282162 NLM ISO Abbreviation: Ned Tijdschr Geneeskd Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms/*surgery , Liver Neoplasms/*surgery , Lung Neoplasms/*surgery, Brain Neoplasms/mortality ; Brain Neoplasms/secondary ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/secondary ; Lung Neoplasms/mortality ; Lung Neoplasms/secondary ; Prognosis ; Treatment Outcome